Hormone Therapy Training: Progesterone for Uterine Bleeding Disorders
One of the most common gynecological problems faced by women of reproductive age, as well as perimenopausal women, is Abnormal Uterine Bleeding (AUB). Whether you are gynecologist, obstetrician, internist, family doctor, or nurse practitioner you have no doubt encountered bleeding problems in your female patients countless times.
One highly effective, efficient, safe, minimally-invasive, long-lasting, and natural method of treating many AUBs is Bioidentical Hormone Replacement Therapy (BHRT) pellets. Utilizing BHRT pellets for progesterone replacement can provide an effectual and convenient approach to regulate menstrual bleeding, alleviate symptoms, and support your patients’ endometrial health.
SottoPelle Method Hormone Therapy Training equips medical professionals with the tools to deliver tailored hormone therapy to their female clients with AUB – optimizing patient outcomes and fostering practice growth. In this article the Hormone Therapy Training experts at SottoPelle Method delve into the ways BHRT pellet training can empower gynecologists and other female healthcare providers to optimize their patients’ medical care.
Progesterone, Progestogens & Uterine Bleeding Disorders
Abnormal Uterine Bleeding (AUB) refers to any menstrual bleeding pattern that deviates from the norm in terms of frequency, duration, volume, or regularity. AUB encompasses a wide range of conditions, including menorrhagia (heavy menstrual bleeding), metrorrhagia (irregular bleeding between periods), and menometrorrhagia (a combination of heavy and irregular bleeding). AUB can have various underlying causes, including hormonal imbalances, structural abnormalities, and systemic disorders.
Progesterone is a naturally occurring hormone produced by the corpus luteum in the ovaries during the second half of the menstrual cycle. Progestogens, on the other hand, are synthetic or natural compounds that mimic the actions of progesterone in the body. Both progesterone and progestogens play crucial roles in the female reproductive system, regulating the menstrual cycle and supporting pregnancy.
Some of the more common UABs that are hormone related include uterine fibroids, adenomyosis, Polycystic Ovary Syndrome (PCOS), and endometrial hyperplasia.
Uterine fibroids, also known as leiomyomas, are noncancerous growths of the uterine muscle. They can vary in size and location within the uterus. Large fibroids or those situated near the uterine lining may disrupt normal menstrual flow, causing heavy bleeding and prolonged periods. Adenomyosis is a condition where the tissue that lines the uterus (endometrium) grows into the uterine muscle (myometrium). This can result in an enlarged, tender uterus and heavy menstrual bleeding.
PCOS is a hormonal disorder that can lead to irregular or absent menstrual periods. Women with PCOS often experience infrequent ovulation, leading to heavy, irregular, or prolonged menstrual bleeding when periods do occur. Endometrial hyperplasia is an overgrowth of the uterine lining (endometrium) that can result from hormonal imbalances, such as excess estrogen relative to progesterone. It can lead to heavy or irregular menstrual bleeding and may increase the risk of endometrial cancer.
Thyroid conditions, including hypothyroidism (underactive thyroid) and hyperthyroidism (overactive thyroid), can also disrupt the menstrual cycle and cause abnormal uterine bleeding.
Hormone Therapy Training for the Management of AUBs
Progesterone and progestogens are pivotal in the management of AUB, particularly in women of reproductive age or those approaching perimenopause. Hormone Therapy to balance progesterones and progestogens can achieve several therapeutic goals, including the following.
Regulating Intermenstrual Bleeding: Progestogens can help establish a more regular menstrual cycle, reducing irregular or unpredictable bleeding episodes.
Decreasing Heavy Menstrual Bleeding (HMB): Progestogens are effective in reducing the volume and duration of menstrual flow, providing relief to women experiencing menorrhagia.
Stabilizing the endometrial Lining: Progestogens counterbalance the effects of estrogen, helping to stabilize the endometrial lining and mitigate uncontrolled growth that may lead to AUB.
BHRT pellets, which contain bioidentical progesterone or other hormones, offer a precise and sustained means of delivering these hormones to individuals experiencing bleeding disorders. Pellets are subcutaneously inserted and gradually release hormones, ensuring a consistent therapeutic effect. This method provides a practical and patient-friendly approach to managing AUB, allowing for tailored treatment regimens based on individual needs.
SottoPelle Method Hormone Therapy Training instructs women’s healthcare providers on the usage, dosing, and insertion of BHRT pellets that provide sustained relief from bleeding disorders. This enables personalized, conservative hormone dosing that is superior to one-size-fits all standard hormone pills. And pellets’ consistent, 24/7 delivery also eliminates both the “roller coaster” of once daily pills – and the ‘user error’ of patients who miss or forget to take daily pills.
Hormone Therapy Training: Other Uses of Progesterone
Balancing progesterone and progestogens is not only of benefit in managing UABs. BHRT to resolve progesterone issues has also been shown in clinical research to prevent endometrial hyperplasia and to reduce the development of endometrial cancer in menopausal women.
In menopausal women, the balance between estrogen and progesterone becomes crucial in maintaining endometrial health. Estrogen dominance without adequate progesterone can lead to endometrial hyperplasia, a precancerous condition. Progestogens administered through BHRT pellets, can help prevent endometrial hyperplasia and reduce the risk of endometrial cancer by opposing the proliferative effects of estrogen on the endometrial lining.
SottoPelle Method Hormone Therapy Training
Understanding the roles of progesterone and progestogens in managing AUB is essential for physicians treating patients with abnormal uterine bleeding disorders. And SottoPelle Method Hormone Therapy Training offers women’s physicians and healthcare providers an exceptional tool to both manage and prevent a wide range of health issues in their female patients – including bleeding disorders.
Utilizing BHRT pellets for hormone replacement therapy can provide an effective and convenient approach to regulate menstrual bleeding, alleviate symptoms, and support endometrial health. Moreover, the judicious use of progesterone and progestogens can significantly contribute to preventing endometrial hyperplasia and reducing the risk of endometrial cancer in menopausal women.
In the rapidly evolving and dramatically growing landscape of women’s healthcare, gynecologists, obstetricians, internists, nurse practitioners and others have an opportunity to provide comprehensive, personalized care by with SottoPelle Method Hormone Therapy Training. If you are a medical professionals who would like to add an effective and lucrative tool to your practice that optimizes patient outcomes and fosters practice growth, call the number below and schedule a consultation with a SottoPelle Method Hormone Therapy Training specialist today.
Physician Hormone Therapy Training: 323.986.5100 (press 1)
Resources:
Cyclical progestogens for heavy menstrual bleeding.
Lethaby A, Irvine G, Cameron I.Cochrane Database Syst Rev. 2008 Jan 23;(1):CD001016. doi: 10.1002/14651858.CD001016.pub2.PMID: 18253983
Cyclical progestogens for heavy menstrual bleeding.
Bofill Rodriguez M, Lethaby A, Low C, Cameron IT.Cochrane Database Syst Rev. 2019 Aug 14;8(8):CD001016. doi: 10.1002/14651858.CD001016.pub3.PMID: 31425626
Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
Lethaby A, Hussain M, Rishworth JR, Rees MC.Cochrane Database Syst Rev. 2015 Apr 30;(4):CD002126. doi: 10.1002/14651858.CD002126.pub3.PMID: 25924648
Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
Lethaby AE, Cooke I, Rees M.Cochrane Database Syst Rev. 2005 Oct 19;(4):CD002126. doi: 10.1002/14651858.CD002126.pub2.PMID: 16235297
Cyclical progestogens for heavy menstrual bleeding.
Lethaby A, Irvine G, Cameron I.Cochrane Database Syst Rev. 2000;(2):CD001016. doi: 10.1002/14651858.CD001016.PMID: 10796587
IMPORTANT DISCLAIMER: This article is provided as general information only and is not intended to be used as medical advice. While the benefits of hormone replacement are well documented through clinical research, we are not representing that hormone therapy is a “cure” for any disease. Only a patient’s treating physician can determine if hormone replacement may be a beneficial part of their healthcare regimen, based on each individual patient’s age, overall health, risk factors, and lifestyle.
